Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 33,741 | 30,893 | 32,607 | 30,340 | 33,637 |
| Cost of Goods | 7,855 | 7,395 | 7,344 | 6,113 | 8,447 |
| Gross Profit | 25,886 | 23,498 | 25,263 | 24,227 | 25,190 |
| Operating Expenses | 40,511 | 41,722 | 36,943 | 36,518 | 39,640 |
| Operating Income | -13,770 | -17,829 | -11,336 | -12,178 | -14,003 |
| Interest Expense | 3 | 3 | 4 | 4 | 5 |
| Other Income | 1,764 | 1,954 | 2,194 | 2,376 | 2,254 |
| Pre-tax Income | -12,009 | -15,878 | -9,146 | -9,806 | -11,754 |
| Income Tax | 88 | 6 | 6 | 10 | 32 |
| Net Income Continuous | -12,097 | -15,884 | -9,152 | -9,816 | -11,786 |
| Net Income | $-12,097 | $-15,884 | $-9,152 | $-9,816 | $-11,786 |
| EPS Basic Total Ops | -0.29 | -0.38 | -0.22 | -0.24 | -0.29 |
| EPS Basic Continuous Ops | -0.29 | -0.38 | -0.22 | -0.24 | -0.29 |
| EPS Diluted Total Ops | -0.29 | -0.38 | -0.22 | -0.24 | -0.29 |
| EPS Diluted Continuous Ops | -0.29 | -0.38 | -0.22 | -0.24 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.29 | -0.38 | -0.22 | -0.24 | -0.29 |
| EBITDA(a) | $-14,523 | $-18,849 | $-12,317 | $-13,468 | $-15,357 |